Business Wire

Sintavia Awarded Hypersonic Development Contract by U.S. Department of Defense

5.6.2024 14:59:00 EEST | Business Wire | Press release

Share

Sintavia, LLC, the world’s first all-digital aerospace component manufacturer, announced today that it had been awarded a contract by the U.S. Department of Defense for the development of additively manufactured hypersonic propulsion components. The contract, part of the Growing Additive Manufacturing Maturity for Airbreathing Hypersonics (“GAMMA-H”) project, contracted through the S²MARTS OTA managed by National Security Technology Accelerator (NSTXL), was awarded in part to Sintavia to develop and prove out the robust quality and operational processes needed to design and manufacture critical precision components needed for hypersonic flight. By validating these processes specifically with respect to hypersonic propulsion components, Sintavia’s efforts under GAMMA-H will be able to be used across the growing hypersonic industrial base. The contract is expected to run through 2025.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240603324018/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

(Photo: Business Wire)

“The GAMMA-H award represents an important step forward in developing and formalizing standard additive manufacturing processes that can be used across the industry for hypersonic production,” said Brian R. Neff, Sintavia’s Founder & CEO. “As the industry leader in this effort, Sintavia is uniquely positioned to work with the GAMMA-H project to successfully develop and validate these processes. We are grateful to the GAMMA-H team for their trust in Sintavia regarding this absolutely critical national security imperative.”

Announced in October 2023 with a budget of $106.7M, the GAMMA-H project is a joint effort between the Office of Secretary of Defense ManTech and the Naval Surface Warfare Center, Crane Division. In addition to the direct GAMMA-H award, Sintavia supports several other efforts also funded by the GAMMA-H project.

About Sintavia

Sintavia is the world’s first all-digital Aerospace & Defense component manufacturer. The company uses generative design to simulate, additively manufacture, post-process, test, and certify a new generation of complex mechanical components for lead system integrators and platform OEMs globally. A founding member of the Additive Manufacturer Green Trade Association, Sintavia is committed to the highest quality standards in the industry and holds multiple Nadcap and other aerospace accreditations, as well as numerous customer supplier recognitions. For more information visit http://www.sintavia.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Sintavia, LLC
Lindsay Lewis
+1 954.474.7800

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

L&T Technology Services Launches Ainfonix ™ 4.0 to Unlock Engineering Intelligence Across Process Industries30.6.2026 13:45:00 EEST | Press release

L&T Technology Services (BSE: 540115, NSE: LTTS), a global leader in Engineering Intelligence Solutions & ER&D Consulting Services, today announced the launch of Ainfonix™ 4.0, a next-generation Engineering Intelligence platform for process industries. Unveiled at EI Live, LTTS’ flagship event that brings together analysts, industry leaders and engineering experts, Ainfonix™ 4.0 marks an important step in the company’s Enterprise AI and Engineering Intelligence strategy. As industrial enterprises accelerate AI adoption, decades of engineering knowledge remain trapped in fragmented drawings, specifications and technical records across disparate systems. Without trusted and accessible engineering data, organizations struggle to realize the full value of AI, automation and digital transformation initiatives. Ainfonix™ 4.0, developed in LTTS’ Sustainability segment, addresses this challenge by transforming engineering artifacts and multi-modal data into structured, asset-linked information

Klick Health Acquires Oxford PharmaGenesis, Bringing Together Unsurpassed Scientific-to-Commercial Capabilities for Life Sciences Clients30.6.2026 13:03:00 EEST | Press release

Focused on taking life sciences companies into the future, Klick Health today announced its acquisition of Oxford PharmaGenesis, the market-leading HealthScience communications consultancy renowned for its scientific and medical expertise, as well as value and market access consulting throughout Europe, Asia-Pacific, and North America. Today’s news brings together two of the leading independent agencies in life sciences. With Oxford PharmaGenesis’ expertise across medical affairs and market access, and Klick's strength in commercial strategy, medical, creative, digital, analytics, and experience design, they can deliver an unparalleled scientific-to-commercial experience. “We are beyond proud to join forces with Chris, Richard, and the entire team at Oxford PharmaGenesis as we focus on helping life sciences clients think holistically about how evidence, medical strategy, access considerations, and stakeholder engagement connect across the lifecycle with a scientific-to-commercial offer

BeOne Medicines Announces Positive Phase 3 Results for BRUKINSA in Frontline Mantle Cell Lymphoma30.6.2026 13:00:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive topline results from the Phase 3 MANGROVE study (BGB-3111-306; NCT04002297) evaluating foundational BTK inhibitor BRUKINSA® (zanubrutinib) plus rituximab versus bendamustine plus rituximab (BR) in adult patients with previously untreated mantle cell lymphoma (MCL). MANGROVE is the first Phase 3, global, randomized trial to evaluate a BTK inhibitor-based chemotherapy-free regimen against standard chemoimmunotherapy in this setting. This pivotal Phase 3 trial builds on the established clinical evidence for BRUKINSA in MCL. Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology, BeOne Medicines, said: “For patients with newly diagnosed MCL, chemotherapy is currently the default. MANGROVE demonstrates for the first time that BRUKINSA plus rituximab, a chemotherapy-free regimen, can deliver unprecedented improvements in progression-free survival, potentially redefining the

Hytera Debuts SC700 Smart 4G Body Camera at CCW 202630.6.2026 12:30:00 EEST | Press release

Hytera, a leading global provider of critical communications technologies and solutions, officially debuted its SC700 Smart 4G Body Camera at Critical Communications World (CCW) 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630283236/en/ Hytera's latest SC700 Smart 4G Body Camera Public safety operations are increasingly moving toward real-time, connected workflows, where communication, video, and situational awareness are integrated to support a faster and more coordinated response in the field. The SC700 is designed to support this shift. It enables live video, location sharing and push-to-talk communication, helping connect frontline officers with control rooms. Integrated with Hytera HyTalk PoC System, it also supports communication across broadband and PMR users to improve coordination across teams. It also features Intelligent Scene Aware, which can detect abnormal situations such as man down, inactivity, or

Global Database Launches Regis, an AI Assistant for Live Company Registry Data30.6.2026 12:13:00 EEST | Press release

Global Database today announced the launch of Regis, a new AI assistant designed to answer business questions using live company data from official government registries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630229011/en/ Unlike general-purpose AI tools that rely on training data or open web sources, Regis is connected to Global Database’s structured company intelligence platform, covering more than 600 million company profiles, sourced from over 400 government registries across more than 200 countries. For more than a decade, Global Database has been collecting, structuring, and maintaining company data directly from government registries around the world. With the launch of Regis, the company is now presenting that information in a new way: through a conversational AI assistant that allows users to ask business questions in plain English and receive structured, source-backed answers. Regis allows users to ask

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye